{"id":"https://openalex.org/W106809472","doi":null,"title":"Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.","display_name":"Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W106809472","mag":"106809472","pmid":"https://pubmed.ncbi.nlm.nih.gov/23377334"},"language":"en","primary_location":{"id":"pmid:23377334","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23377334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075798284","display_name":"Alan Menter","orcid":"https://orcid.org/0000-0002-9314-0007","observed_orcids":["https://orcid.org/0000-0002-9314-0007"]},"institutions":[{"id":"https://openalex.org/I2802366037","display_name":"Baylor University Medical Center","ror":"https://ror.org/03nxfhe13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802366037","https://openalex.org/I4210160418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Menter","raw_affiliation_strings":["Dermatology Department, Baylor University Medical Center, Dallas, TX, USA. amderm@gmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department, Baylor University Medical Center, Dallas, TX, USA. amderm@gmail.com","institution_ids":["https://openalex.org/I2802366037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048521405","display_name":"Linda Stein Gold","orcid":"https://orcid.org/0000-0002-2758-1605","observed_orcids":["https://orcid.org/0000-0002-2758-1605"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda Stein Gold","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054928299","display_name":"Michael Bukhalo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114824","display_name":"Arlington Dermatology","ror":"https://ror.org/02hkdst29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114824"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Bukhalo","raw_affiliation_strings":["Altman Dermatology Associates"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Altman Dermatology Associates","institution_ids":["https://openalex.org/I4210114824"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082903375","display_name":"Steven K. Grekin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086739","display_name":"Grekin Skin Institute","ror":"https://ror.org/002s05q87","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086739"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Grekin","raw_affiliation_strings":["Grekin Skin Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grekin Skin Institute","institution_ids":["https://openalex.org/I4210086739"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112794056","display_name":"Steven E. Kempers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Kempers","raw_affiliation_strings":["Minnesota Clinical Study Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Minnesota Clinical Study Center","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057136462","display_name":"Brent Boyce","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132298","display_name":"Great Lakes Research Group (United States)","ror":"https://ror.org/03xerja39","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132298"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brent M Boyce","raw_affiliation_strings":["Great Lakes Research Group Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Great Lakes Research Group Inc","institution_ids":["https://openalex.org/I4210132298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025677565","display_name":"Cecilia Ganslandt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cecilia Ganslandt","raw_affiliation_strings":["LEO Pharma AS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LEO Pharma AS","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061759213","display_name":"John Villumsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Villumsen","raw_affiliation_strings":["LEO Pharma AS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LEO Pharma AS","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038505651","display_name":"Mark Lebwohl","orcid":"https://orcid.org/0000-0002-4705-5303","observed_orcids":["https://orcid.org/0000-0002-4705-5303"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Lebwohl","raw_affiliation_strings":["Icahn School of Medicine at Mount Sinai (ISMMS)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Icahn School of Medicine at Mount Sinai (ISMMS)","institution_ids":["https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.3049,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.92258174,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"12","issue":"1","first_page":"92","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calcipotriol","display_name":"calcipotriol","score":0.9150000214576721},{"id":"https://openalex.org/keywords/betamethasone-dipropionate","display_name":"betamethasone dipropionate","score":1.0},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.972000002861023},{"id":"https://openalex.org/keywords/topical-combination-therapy","display_name":"topical combination therapy","score":0.6589999794960022},{"id":"https://openalex.org/keywords/topical-suspension","display_name":"topical suspension","score":0.8190000057220459},{"id":"https://openalex.org/keywords/disease-control","display_name":"disease control","score":0.492000013589859},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6430000066757202},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4740000069141388}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9040267467498779},{"id":"https://openalex.org/C2779800615","wikidata":"https://www.wikidata.org/wiki/Q4897349","display_name":"Betamethasone dipropionate","level":3,"score":0.9009597301483154},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7123218774795532},{"id":"https://openalex.org/C2781162121","wikidata":"https://www.wikidata.org/wiki/Q416132","display_name":"Betamethasone","level":2,"score":0.5778876543045044},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5648384094238281},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5109567046165466},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.49312207102775574},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4758871793746948},{"id":"https://openalex.org/C2776009542","wikidata":"https://www.wikidata.org/wiki/Q155683","display_name":"Calcipotriol","level":3,"score":0.44853878021240234},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2513383626937866},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2275668978691101}],"mesh":[{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001623","descriptor_name":"Betamethasone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001623","descriptor_name":"Betamethasone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D001623","descriptor_name":"Betamethasone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007070","descriptor_name":"Immunoglobulin A","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013535","descriptor_name":"Suspensions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014677","descriptor_name":"Pharmaceutical Vehicles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023381","descriptor_name":"Endpoint Determination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:23377334","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23377334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},{"id":"mag:106809472","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23377334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2288818256","https://openalex.org/W2163031644","https://openalex.org/W1999832192","https://openalex.org/W2509183933","https://openalex.org/W2154234582","https://openalex.org/W2075016651","https://openalex.org/W2418299234","https://openalex.org/W2000142077","https://openalex.org/W3155729122","https://openalex.org/W4294650500"],"abstract_inverted_index":{"BACKGROUND/OBJECTIVES:":[0],"A":[1],"combination":[2],"topical":[3,56,69,205],"suspension/gel":[4],"containing":[5,58,207],"calcipotriene":[6,59,146,176,208],"plus":[7,60,147,177,209],"betamethasone":[8,61,148,178,210],"dipropionate":[9,62,211],"has":[10,30],"been":[11],"developed":[12],"as":[13],"a":[14,35,55,88,139,166,219],"safe":[15,220],"and":[16,38,52,68,83,122,128,159,194,221],"effective":[17,222],"treatment":[18,74,161,190,224],"for":[19,42,214,225],"patients":[20],"with":[21,64,154,184],"psoriasis":[22,43,79,216,226],"vulgaris":[23,227],"of":[24,54,75,105,116,142,172],"the":[25,31,45,50,73,81,103,112,145,157,175,187,201,229],"scalp.":[26],"This":[27,47,86],"same":[28],"preparation":[29],"potential":[32],"to":[33,77],"be":[34],"convenient,":[36],"effective,":[37],"cosmetically":[39],"appealing":[40],"formulation":[41],"on":[44,80,111,228],"body.":[46,230],"trial":[48,93],"evaluated":[49],"efficacy":[51,99],"safety":[53,196],"suspension":[57,70,206],"compared":[63,153,183],"its":[65],"constituent":[66],"components":[67],"vehicle":[71],"in":[72,94,144,156,174,186],"mild":[76],"moderate":[78],"trunk":[82],"limbs.":[84],"METHODS:":[85],"was":[87],"randomized,":[89],"double-blind,":[90],"vehicle-controlled,":[91],"4-arm":[92],"1,152":[95],"subjects.":[96],"The":[97,204],"co-primary":[98],"end":[100],"points":[101],"were":[102,132,198],"proportion":[104,141,171],"subjects":[106,143,155,173,185],"achieving":[107],"controlled":[108,151,181],"disease":[109,117,152,182],"based":[110],"Investigators'":[113],"Global":[114],"Assessment":[115],"severity":[118],"at":[119],"weeks":[120],"4":[121],"8.":[123],"Adverse":[124,192],"events,":[125],"vital":[126],"signs,":[127],"clinical":[129],"laboratory":[130],"measurements":[131],"also":[133,218],"assessed.":[134],"RESULTS:":[135],"At":[136,163],"week":[137,164],"4,":[138],"greater":[140,170],"group":[149,179],"achieved":[150,180],"calcipotriene-only":[158],"vehicle-only":[160],"groups.":[162,191,202],"8,":[165],"statistically":[167],"significantly":[168],"(P<.01)":[169],"3":[188],"other":[189,195],"events":[193],"assessments":[197],"similar":[199],"between":[200],"CONCLUSION:":[203],"traditionally":[212],"used":[213],"scalp":[215],"is":[217],"once-daily":[223]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}